Effective October 30th, 2023, financial support for Dexcom G6 or Dexcom G7 Real-time Continuous Glucose Monitoring (rtCGM) supplies is available for medically eligible New Brunswickers living with Type 1 diabetes and with Type 2 diabetes on intensive insulin therapy, requiring 3 or more insulin injections per day.

Clients must have a valid New Brunswick Medicare number and meet the medical eligibility criteria. Applications for CGM coverage must be initiated by the client’s regular healthcare provider who supports the management of their diabetes. This includes their diabetes specialist, GP/NP, or Certified Diabetes Educator in a diabetes clinic.